IZI Medical Products, Inc., headquartered in the United States, is a leading provider in the medical device industry, specialising in innovative imaging solutions. Founded in 1988, the company has established a strong presence across various operational regions, focusing on enhancing patient care through advanced technology. The core offerings of IZI Medical Products include a range of imaging products, such as contrast agents and imaging accessories, designed to improve diagnostic accuracy and patient outcomes. Their commitment to quality and innovation has positioned them as a trusted partner in the healthcare sector. With a reputation for excellence, IZI Medical Products has achieved significant milestones, including numerous industry recognitions for their contributions to medical imaging. Their unique approach to product development ensures they remain at the forefront of the market, continually meeting the evolving needs of healthcare professionals.
How does IZI Medical Products, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
IZI Medical Products, Inc.'s score of 57 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
IZI Medical Products, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Halma plc, which provides emissions data cascaded from its parent organisation. However, no specific emissions figures or reduction targets have been disclosed for IZI Medical Products, Inc. As part of its commitment to sustainability, IZI Medical Products, Inc. aligns with the broader climate initiatives of Halma plc. While there are no documented reduction targets or climate pledges specific to IZI Medical Products, the parent company is known for its commitment to reducing carbon emissions and enhancing sustainability practices across its subsidiaries. In summary, while IZI Medical Products, Inc. does not currently report specific emissions data or reduction initiatives, it is part of a corporate family that prioritises climate action and sustainability.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 4,771,000 | 0,000,000 | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,043,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 17,281,000 | 00,000,000 | - | 0,000,000 | - | 00,000,000 | 000,000,000 | 000,000,000 |
IZI Medical Products, Inc.'s Scope 3 emissions, which increased by 2% last year and increased significantly since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 52% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
IZI Medical Products, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.